SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-002732
Filing Date
2021-11-03
Accepted
2021-11-03 08:00:33
Documents
17
Period of Report
2021-11-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dawn-20211103.htm   iXBRL 8-K 56082
2 EX-99.1 dawn-ex99_1.htm EX-99.1 35260
3 EX-99.2 dawn-ex99_2.htm EX-99.2 9830
4 GRAPHIC img109617361_0.jpg GRAPHIC 20511
5 GRAPHIC dawn-ex99_2s1.jpg GRAPHIC 109723
6 PDF COURTESY COPY dawn-ex99_2.pdf EX-99.2 1946711
  Complete submission text file 0000950170-21-002732.txt   3095865

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20211103_pre.xml EX-101.PRE 10289
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20211103_lab.xml EX-101.LAB 14010
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20211103.xsd EX-101.SCH 2490
10 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20211103_htm.xml XML 4955
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 211373764
SIC: 2834 Pharmaceutical Preparations